Belite Bio (BLTE) Reports In-Line Q4 EPS

Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture (ACN) spreader of 22700 contracts of August 120 puts and 22200 contracts of August 130 calls as share price down 7.2%
• Trump: everybody is fully aware that Iran will agree to have major weapons inspections in order to ensure "nuclear honesty" long into future